Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Postexposure chemoprophylaxis for occupational exposures to the human immunodeficiency virus.

× No keyword cloud information.

10 in total

1. Use of stored serum from Uganda for development and evaluation of a human immunodeficiency virus type 1 testing algorithm involving multiple rapid immunoassays.

Authors: Darrell E Singer; Noah Kiwanuka; David Serwadda; Fred Nalugoda; Linda Hird; Jamie Bulken-Hoover; Godfrey Kigozi; Jennifer A Malia; Eva K Calero; Warren Sateren; Merlin L Robb; Fred Wabwire-Mangen; Maria Wawer; Ronald H Gray; Nelson Sewankambo; Deborah L Birx; Nelson L Michael
Journal: J Clin Microbiol Date: 2005-10 Impact factor: 5.948

Review 2. Nosocomial spread of viral disease.

Authors: C Aitken; D J Jeffries
Journal: Clin Microbiol Rev Date: 2001-07 Impact factor: 26.132

3. Post-exposure prophylaxis for human immunodeficiency virus: knowledge and experience of junior doctors.

Authors: M Y Chen; E F Fox; C A Rogers
Journal: Sex Transm Infect Date: 2001-12 Impact factor: 3.519

4. Susceptibility of the porcine endogenous retrovirus to reverse transcriptase and protease inhibitors.

Authors: S H Qari; S Magre; J G García-Lerma; A I Hussain; Y Takeuchi; C Patience; R A Weiss; W Heneine
Journal: J Virol Date: 2001-01 Impact factor: 5.103

5. Inadequate hepatitis B vaccination and post-exposure evaluation among transplant surgeons: prevalence, correlates, and implications.

Authors: Scott D Halpern; David A Asch; Abraham Shaked; Peter Stock; Emily A Blumberg
Journal: Ann Surg Date: 2006-08 Impact factor: 12.969

Review 6. Tolerability of postexposure antiretroviral prophylaxis for occupational exposures to HIV.

Authors: L M Lee; D K Henderson
Journal: Drug Saf Date: 2001 Impact factor: 5.606

7. Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy.

Authors: Robert J O'Connell; Teresa M Merritt; Jennifer A Malia; Thomas C VanCott; Matthew J Dolan; Hassan Zahwa; William P Bradley; Bernard M Branson; Nelson L Michael; Caroline C De Witt
Journal: J Clin Microbiol Date: 2003-05 Impact factor: 5.948

Postexposure chemoprophylaxis for occupational exposures to the human immunodeficiency virus.